IA
GTHX

IndexIQ Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

IndexIQ Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19,006
Closed -$342K – 1349
2020
Q4 		$342K Buy
19,006
+1,962
+12% +$29.3K 0.01% 576
2020
Q3 		$197K Buy
17,044
+924
+6% +$15.3K 0.01% 658
2020
Q2 		$391K Buy
16,120
+465
+3% +$7.69K 0.02% 271
2020
Q1 		$173K Buy
+15,655
New +$292K 0.01% 707

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IndexIQ Advisors's GTHX Position: Q1 2021 in Review

IndexIQ Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2021, closing a stake of 19,006 shares — an estimated $342K sold.

IndexIQ Advisors first reported a position in GTHX in Q1 2020 and held it in 4 quarters. The position peaked at $391K in Q2 2020. 123 funds tracked by Wall St. Rank hold GTHX as of Q1 2021.

  • IndexIQ Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • IndexIQ Advisors sold 19,006 G1 Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $342K.
  • IndexIQ Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • IndexIQ Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $391K in Q2 2020.
  • 123 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2021.

Based on IndexIQ Advisors's 13F filing for Q1 2021, filed 7 May 2021.